Lower Risk of New‐Onset Atrial Fibrillation in Conduction System Pacing Compared With Right Ventricular Pacing
Pacing and Clinical Electrophysiology · 2025-02 · 48 (2) · 202-215
DOI: 10.1111/pace.15121 ↗At a glance
Vergleichsstudie in Pacing and Clinical Electrophysiology, published online on 2025-01-15. Written by Feng Li and 9 co-authors. Institution: Department of Cardiology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. Major MEDLINE topics: Atrial Fibrillation, Cardiac Pacing, Artificial, Heart Conduction System. Cited 10 times so far (Crossref); 32 references. Funded by: Suzhou Science and Technology Plan Project, Natural Science Foundation of the Jiangsu Higher Education Insititutions of China, The Applied Basic Research (medical and health) Science and Technology Innovation Project of Suzhou.
Abstract (original language)
Background
Conduction system pacing (CSP) has been reported to improve clinical outcomes in comparison of right ventricular pacing (RVP). However, the performance between CSP and RVP on the risk of new‐onset atrial fibrillation (AF) remains elusive.
Methods
Four online databases were systematically searched up to July 1, 2024. Studies comprising the rate/risk of new‐onset AF between CSP and RVP group were included. Subgroup analysis was performed to screen the potential determinants for the new‐onset AF risk for CSP therapy. The pooled risk of new‐onset AF based on ventricular pacing burden (Vp) between CSP and RVP group were evaluated.
Results
A total of six studies including 1577 patients requiring pacing therapy were eligible. The pooled new‐onset AF rates for CSP and RVP group were 0.09 and 0.27, respectively. Compared with RVP group, CSP group showed a lower pooled risk (risk ratio [RR] 0.38, p = 0.000) and adjusted risk (hazard ratio [HR] 0.32, p = 0.000) of new‐onset AF. Meanwhile, a significant intervention–covariate interaction for the adjusted risk of new‐onset AF between CSP and RVP group was identified with Vp < 20% and Vp ≥ 20%.
Conclusions
Our study suggests that CSP is associate with a significantly lower occurrence of new‐onset AF compared with RVP. The Vp ≥ 20% may be the key determinant on the lower risk of new‐onset AF with CSP therapy. Trial Registration https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023492551 , identifier (CRD42023492551)
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Cardiology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
- Division of Cardiology, Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA.
- Geisinger Heart Institute, Geisinger Wyoming Valley Medical Center, WilkesBarre, Pennsylvania, USA.
ORCID profiles: Feng Li, Venkatesh Ravi
Funding
- Suzhou Science and Technology Plan Project
- Natural Science Foundation of the Jiangsu Higher Education Insititutions of China
- The Applied Basic Research (medical and health) Science and Technology Innovation Project of Suzhou
Cite
APA
Li, F., Zhang, Y., Huang, J., Peng, S. L., Jin, M. C., Geng, C., Ravi, V., Sharma, P. S., Vijayaraman, P., & Li, H. (2025). Lower Risk of New‐Onset Atrial Fibrillation in Conduction System Pacing Compared With Right Ventricular Pacing. Pacing and Clinical Electrophysiology, 48(2), 202-215. https://doi.org/10.1111/pace.15121
Vancouver
Li F, Zhang Y, Huang J, Peng SL, Jin MC, Geng C, et al. Lower Risk of New‐Onset Atrial Fibrillation in Conduction System Pacing Compared With Right Ventricular Pacing. Pacing and Clinical Electrophysiology. 2025;48(2):202-215. doi:10.1111/pace.15121
BibTeX
@article{Li2025,
author = {Li, Feng and Zhang, You and Huang, Jian and Peng, Si-Liang and Jin, Meng-Chao and Geng, Chi and Ravi, Venkatesh and Sharma, Parikshit S and Vijayaraman, Pugazhendhi and Li, Hui},
title = {Lower Risk of New‐Onset Atrial Fibrillation in Conduction System Pacing Compared With Right Ventricular Pacing},
journal = {Pacing and Clinical Electrophysiology},
year = {2025},
volume = {48},
number = {2},
pages = {202--215},
doi = {10.1111/pace.15121}
}
EUVIMED